1Kearney D, Fizgerald D.The antithrombotic effect of statins. J Am Cardiol, 1999, 33:1305-1307. 被引量：1
2Law MR, Wald NJ, Rudnicka AR, et al. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ, 2003, 326: 1423. 被引量：1
3van Oostrom AJ, van Wijk J, Cabezas MC. Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis. Drugs, 2004, 64:19-41. 被引量：1
4Ridker PM, Rifain N, Pfeffer MA, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation, 1999, 100:230-235. 被引量：1
5Das UN. Statins and the prevention of dementia. CAMJ, 2001, 165:908-909. 被引量：1
6Bjorkhem I, Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol, 2004, 24:806-815. 被引量：1
7Locatelli S, Lutjohann D, Schmidt HH. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. Arch Neurol, 2002, 59:213-216. 被引量：1
8Vega GL, Weiner MF, Lipton AM, et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch Neurology, 2003, 60:510-515. 被引量：1
9Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet,2004, 363:1139-1146. 被引量：1
10Elkins JS, O'Meara ES, Longstreth WT Jr, et al. Stroke risk factors and loss of high cognitive function. Neurology, 2004, 63: 793-799. 被引量：1
